IZUMO2

gene
On this page

Also known as MGC33947SCRL

Summary

IZUMO2 (IZUMO family member 2, HGNC:28518) is a protein-coding gene on chromosome 19q13.33, encoding Izumo sperm-egg fusion protein 2 (Q6UXV1).

Predicted to be located in membrane.

Source: NCBI Gene 126123 — RefSeq curated summary.

At a glance

  • Clinical variants (ClinVar): 41 total
  • MANE Select transcript: NM_152358

Identifiers

Gene identifiers

FieldValue
HGNC IDHGNC:28518
Approved symbolIZUMO2
NameIZUMO family member 2
Location19q13.33
Locus typegene with protein product
StatusApproved
AliasesMGC33947, SCRL
Ensembl geneENSG00000161652
Ensembl biotypeprotein_coding
OMIM618895
Entrez126123

Gene structure

Transcript identifiers

Ensembl transcripts: 5 — 3 protein_coding, 2 nonsense_mediated_decay

ENST00000293405, ENST00000486050, ENST00000594854, ENST00000600293, ENST00000916628

RefSeq mRNA: 2 — MANE Select: NM_152358 NM_001321449, NM_152358

CCDS: CCDS12792

Canonical transcript exons

ENST00000293405 — 7 exons

ExonStartEnd
ENSE000010594935016273950162813
ENSE000017515445015254850152651
ENSE000019185805016296350163281
ENSE000035593865015826850158348
ENSE000035783615015460050154726
ENSE000036727865015923050159250
ENSE000036769495015949450159580

Expression profiles

Bgee: expression breadth broad, 82 present calls, max score 93.99.

FANTOM5 (CAGE): breadth tissue_specific, TPM avg 0.0909 / max 38.7933, expressed in 38 samples.

FANTOM5 promoters (2 alternative TSS)

Promoter IDTPM avgSamples expressed
1821420.062933
1821410.02805

Top tissues by expression

208 total, by Bgee expression score (0-100, higher = more expressed):

TissueAnatomy IDExpression scoreQuality
left testisUBERON:000453393.99gold quality
right testisUBERON:000453493.89gold quality
spermCL:000001993.14gold quality
testisUBERON:000047390.51gold quality
male germ line stem cell (sensu Vertebrata) in testisCL:0000089 ∩ UBERON:000047383.37gold quality
adult organismUBERON:000702371.85gold quality
primordial germ cell in gonadCL:0000670 ∩ UBERON:000099171.25gold quality
upper arm skinUBERON:000426364.25gold quality
buccal mucosa cellCL:000233663.83gold quality
secondary oocyteCL:000065559.46gold quality
tibialis anteriorUBERON:000138558.96silver quality
nasal cavity epitheliumUBERON:000538457.45gold quality
mucosa of paranasal sinusUBERON:000503057.34gold quality
parotid glandUBERON:000183156.48gold quality
vena cavaUBERON:000408755.42gold quality
cardiac muscle of right atriumUBERON:000337954.84gold quality
superficial temporal arteryUBERON:000161454.80gold quality
cortical plateUBERON:000534354.75gold quality
left ventricle myocardiumUBERON:000656654.23gold quality
kidney epitheliumUBERON:000481953.93gold quality
pericardiumUBERON:000240753.72gold quality
epithelial cell of pancreasCL:000008353.62gold quality
deltoidUBERON:000147652.42gold quality
pancreatic ductal cellCL:000207951.51silver quality
tendon of biceps brachiiUBERON:000818851.08gold quality
lower lobe of lungUBERON:000894950.52silver quality
myocardiumUBERON:000234950.46gold quality
oocyteCL:000002347.84gold quality
quadriceps femorisUBERON:000137747.81gold quality
tracheaUBERON:000312647.41gold quality

Single-cell (SCXA)

Detected in 2 experiment(s), a significant marker in 1.

ExperimentMarker?Max mean expression
E-ANND-3yes3.39
E-MTAB-7303no7.25

Regulation

Is transcription factor: no

Literature-anchored findings (GeneRIF, showing 1)

  • Expression of IZUMO2 in colorectal cancer in association with clinicopathological features. (PMID:38484656)

Cross-species orthologs

2 orthologs

OrganismSymbolGene ID
mus_musculusIzumo2ENSMUSG00000066500
rattus_norvegicusIzumo2ENSRNOG00000065701

Protein

Protein identifiers

Izumo sperm-egg fusion protein 2Q6UXV1 (reviewed: Q6UXV1)

All UniProt accessions (4): Q6UXV1, M0QXA9, M0QZG1, M0R2L8

UniProt curated annotations — full annotation on UniProt →

Subcellular location. Membrane.

Miscellaneous. Izumo is the name of a Japanese shrine to marriage.

Similarity. Belongs to the Izumo family.

Isoforms (2)

UniProt IDNamesCanonical?
Q6UXV1-11yes
Q6UXV1-22

RefSeq proteins (2): NP_001308378, NP_689571* (*=MANE)

Domains & families (InterPro)

IDNameType
IPR029389IZUMOFamily
IPR042920IZUMO2Family

Pfam: PF15005

UniProt features (8 total): topological domain 2, signal peptide 1, chain 1, transmembrane region 1, glycosylation site 1, splice variant 1, sequence variant 1

Structure

Experimental structures (PDB)

0 structures.

Predicted structure (AlphaFold)

ModelpLDDTFraction very-high
AF-Q6UXV1-F186.820.68

Functional residue map

Curated UniProt residues grouped by drug-discovery relevance — catalytic, ligand-binding, modification, and mutation-validated positions. Source: UniProtKB sequence features.

Glycosylation sites (1): 91

Function

Pathways and Gene Ontology

Reactome pathways

3 pathways

IDPathway
R-HSA-1300645Acrosome Reaction and Sperm:Oocyte Membrane Binding
R-HSA-1187000Fertilization
R-HSA-1474165Reproduction

MSigDB gene sets: 11 (showing top): REACTOME_FERTILIZATION, REACTOME_ACROSOME_REACTION_AND_SPERM_OOCYTE_MEMBRANE_BINDING, REACTOME_REPRODUCTION, ZIM3_TARGET_GENES, ZNF596_TARGET_GENES, GSE14769_UNSTIM_VS_240MIN_LPS_BMDM_DN, GSE2706_LPS_VS_R848_AND_LPS_2H_STIM_DC_DN, chr19q13, GSE2585_CTEC_VS_THYMIC_DC_UP, GSE5589_WT_VS_IL10_KO_LPS_AND_IL6_STIM_MACROPHAGE_45MIN_UP, GSE41176_UNSTIM_VS_ANTI_IGM_STIM_TAK1_KO_BCELL_1H_DN

GO Biological Process (0):

GO Molecular Function (0):

GO Cellular Component (1): membrane (GO:0016020)

Reactome top-level categories

Rollup of top-2 pathways:

CategoryPathways
Fertilization1
Reproduction1

GO top-level categories

Rollup of top GO terms by namespace:

CategoryTerms
cellular anatomical structure1

Protein interactions and networks

STRING

248 interactions, top by confidence (×1000):

Protein AProtein BPartner UniProtScore
IZUMO2IZUMO3Q5VZ72843
IZUMO2IZUMO4Q1ZYL8825
IZUMO2IZUMO1Q8IYV9726
IZUMO2ISOC2Q96AB3574
IZUMO2ADAM32Q8TC27560
IZUMO2ADAM2P78326528
IZUMO2OR4N5Q8IXE1525
IZUMO2SPACA4Q8TDM5519
IZUMO2OR4K14Q8NGD5507
IZUMO2RASIP1Q5U651471
IZUMO2GLIPR1L1Q6UWM5460
IZUMO2UNC50Q53HI1447
IZUMO2ZNF556Q9HAH1446
IZUMO2SPACA1Q9HBV2392
IZUMO2TEKT5Q96M29372

IntAct

0 interactions, top by confidence:

BioGRID (1): IZUMO2 (Two-hybrid)

ESM2 similar proteins: A0A1B0GUA7, A0A3Q1LRJ2, A2T6Z6, E9Q8Q8, O46673, O77049, O88823, P01588, P07865, P22301, P29676, P43480, P46651, P48411, P51496, P51497, P51746, P55029, P79338, Q0Z972, Q25BC1, Q28374, Q28C41, Q2PE73, Q3KNT9, Q4VK74, Q5Q0V6, Q5ZJY9, Q6A2H4, Q6AY06, Q6H8S9, Q6H8T0, Q6H8T1, Q6H8T2, Q6UXV1, Q865X4, Q8BGT0, Q8CGK6, Q8CJ70, Q8IU54

Diamond homologs: A6PWV3, A6QL94, Q5VZ72, Q6UXV1, Q9DA16

SIGNOR signaling

0 interactions.

Disease & clinical

Clinical variants and AI predictions

ClinVar

41 variants total. Per-class counts are floors (≥ shown; pagination cap):

ClassificationCount (floor)
Pathogenic0
Likely pathogenic0
Uncertain significance36
Likely benign4
Benign0

Top pathogenic / likely-pathogenic (0)

SpliceAI

917 predictions. Top by Δscore:

VariantEffectΔscore
19:50158262:GCTTA:Gdonor_loss1.0000
19:50158263:CTTAC:Cdonor_loss1.0000
19:50158265:TA:Tdonor_loss1.0000
19:50158266:ACC:Adonor_loss1.0000
19:50158267:C:CGdonor_loss1.0000
19:50158346:AGCC:Aacceptor_loss1.0000
19:50158347:GCCT:Gacceptor_loss1.0000
19:50158348:CCTA:Cacceptor_loss1.0000
19:50158349:CT:Cacceptor_loss1.0000
19:50158350:T:Aacceptor_loss1.0000
19:50159521:T:Adonor_gain1.0000
19:50159529:T:TAdonor_gain1.0000
19:50162812:CT:Cacceptor_gain1.0000
19:50162814:C:CCacceptor_gain1.0000
19:50162959:GCAC:Gdonor_loss1.0000
19:50162962:C:CAdonor_loss1.0000
19:50162962:CCCA:Cdonor_gain1.0000
19:50162965:A:ACdonor_gain1.0000
19:50162966:C:CCdonor_gain1.0000
19:50162969:T:Adonor_gain1.0000
19:50162984:T:Adonor_gain1.0000
19:50162993:AGT:Adonor_gain1.0000
19:50162993:AGTC:Adonor_gain1.0000
19:50158266:A:ACdonor_gain0.9900
19:50158267:C:CCdonor_gain0.9900
19:50158344:CAAGC:Cacceptor_gain0.9900
19:50158347:GC:Gacceptor_gain0.9900
19:50158348:CC:Cacceptor_gain0.9900
19:50158349:C:CCacceptor_gain0.9900
19:50162809:TGTCT:Tacceptor_gain0.9900

AlphaMissense

1418 scored. Top likely-pathogenic:

VariantProtein changeam_pathogenicity
19:50162976:A:CF73L0.979
19:50162976:A:TF73L0.979
19:50162978:A:GF73L0.979
19:50158273:C:GC164S0.967
19:50158274:A:TC164S0.967
19:50158322:A:GC148R0.966
19:50163001:A:CF65C0.966
19:50159247:C:TC133Y0.964
19:50158272:G:CC164W0.963
19:50159247:C:GC133S0.961
19:50159248:A:TC133S0.961
19:50159546:C:AR114S0.960
19:50159546:C:GR114S0.960
19:50159522:C:AK122N0.959
19:50159522:C:GK122N0.959
19:50159559:A:GL110P0.959
19:50163003:G:CF64L0.958
19:50163003:G:TF64L0.958
19:50163005:A:GF64L0.958
19:50158273:C:TC164Y0.956
19:50158321:C:GC148S0.956
19:50158322:A:TC148S0.956
19:50163063:G:CF44L0.956
19:50163063:G:TF44L0.956
19:50163065:A:GF44L0.956
19:50163064:A:CF44C0.955
19:50158274:A:GC164R0.953
19:50159232:C:GC138S0.953
19:50159233:A:TC138S0.953
19:50163134:A:GC21R0.952

dbSNP variants (sampled 300 via entrez): RS1000234823 (19:50163190 G>A), RS1000291839 (19:50156871 C>T), RS1000349301 (19:50160544 G>A), RS1000524192 (19:50154421 G>A), RS1000992310 (19:50160784 C>A,T), RS1001434997 (19:50155689 T>G), RS1002082787 (19:50153775 A>C,T), RS1002502064 (19:50160448 T>C), RS1002723444 (19:50164789 T>G), RS1002994364 (19:50152489 G>A), RS1003101295 (19:50159010 T>C), RS1003487882 (19:50165116 A>G), RS1004217555 (19:50157909 A>AT), RS1004375298 (19:50154794 A>C,G), RS1004689549 (19:50163738 G>A,C,T)

Disease associations

OMIM: gene MIM:618895 | disease phenotypes:

GenCC curated gene-disease

Mondo (0):

Orphanet (0):

HPO phenotypes

0 total (0 of 0 shown, HPO-id order):

GWAS associations

0 associations (top):

Drugs & pharmacology

Drug and pharmacology data

Is drug target: no

PharmGKB: 1 entry (VIP=true, CPIC=false)

CTD chemical–gene interactions

8 total (human), top 8 by PubMed support.

ChemicalActions (top 5)PubMed papers
bisphenol Adecreases methylation1
sodium arseniteincreases expression1
perfluorooctanoic acidincreases expression1
aflatoxin B2increases methylation1
perfluorooctane sulfonic acidincreases expression1
Acetaminophenincreases expression1
Benzo(a)pyreneaffects methylation, decreases methylation, increases methylation1
Aflatoxin B1decreases methylation1

Clinical trials (associated diseases)

0 trials via MONDO — disease-level, not drug-specific.

No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.